Simplex Trading
CABA icon

Simplex Trading’s Cabaletta Bio CABA Stock Holding History

Simplex Trading’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,638
Closed -$26.8K – 8564
2024
Q3 		$36K Buy
7,638
+1,434
+23% +$8.3K ﹤0.01% 6179
2024
Q2 		$46K Buy
+6,204
New +$76K ﹤0.01% 6168
2022
Q4 		– Sell
-24,310
Closed -$88.5K – 9266
2022
Q3 		$15K Buy
24,310
+19,851
+445% +$23.9K ﹤0.01% 7806
2022
Q2 		$4K Sell
4,459
-15,076
-77% -$21.3K ﹤0.01% 8934
2022
Q1 		$39K Sell
19,535
-14,703
-43% -$38.4K ﹤0.01% 7464
2021
Q4 		$129K Buy
34,238
+28,657
+513% +$306K ﹤0.01% 5844
2021
Q3 		$46K Hold
5,581
– – ﹤0.01% 7588
2021
Q2 		$47K Buy
5,581
+4,764
+583% +$46.8K ﹤0.01% 7695
2021
Q1 		$9K Buy
+817
New +$9.98K ﹤0.01% 7933

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Simplex Trading's CABA Position: Q4 2024 in Review

Simplex Trading sold out of Cabaletta Bio (CABA) in Q4 2024, closing a stake of 7,638 shares — an estimated $26.8K sold.

Simplex Trading first reported a position in CABA in Q1 2021 and held it in 9 quarters. The position peaked at $129K in Q4 2021. 108 funds tracked by Wall St. Rank hold CABA as of Q4 2024.

  • Simplex Trading reported no remaining Cabaletta Bio position as of Q4 2024 after selling out during the quarter.
  • Simplex Trading sold 7,638 Cabaletta Bio shares in Q4 2024, an estimated $26.8K.
  • Simplex Trading first reported a position in Cabaletta Bio in Q1 2021 and held it in 9 quarters.
  • Simplex Trading's Cabaletta Bio position peaked at $129K in Q4 2021.
  • 108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q4 2024.

Based on Simplex Trading's 13F filing for Q4 2024, filed 11 Feb 2025.